Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs

 

Lighting Up the IP Debate

Victoria Hale, head of OneWorld Health, an innovative non-profit pharmaceutical firm, reckons that compulsory licensing could prove "the last blow" that pushes the drug industry away from looking for cures for diseases of the poor world, which are already woefully neglected...

Bruce Lehman, a lawyer who worked on the TRIPS [sic] accord in the Clinton administration, thinks it is cynical for middle-income countries "to avoid paying their fair share of drug-discovery costs."